Tome Biosciences Stock
HealthTechLooking to sell Tome Biosciences stock or options?
Tome Biosciences is a biotechnology company that specializes in programmable gene insertion technology. They facilitate the insertion of genetic sequences of any size into any location within a genome, aiming to identify and eliminate DNA from similar bacteriophages during future infections. This innovative approach enables patient cures through advanced cell and genome engineering techniques.
Investors Include:
GV, Longwood Fund, ARCH Venture Partners, Polaris Partners, FujiFilm, Andreessen Horowitz, Bruker, Alexandria Venture Investments.